BDEC Performance — Innovator U.S. Equity Buffer ETF - December
Data updated: 2026-09-28
BDEC returned +7.87% year to date and +16.41% over one year to Jul 2026. Annualised returns are +12.75% over 3 years and +9.85% over 5 years. The fund trailed its US Blend category average: $100 invested three years ago grew to $143, against $147 for the category, and to $116 over one year, against $120. Volatility over the past three years was 9.41% a year. In the 12 months to Jul 2026 the fund lost a net $33.3M, and assets reached $217.75M.
BDEC Growth of $100
What $100 invested in Innovator U.S. Equity Buffer ETF - December grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Blend category average over the same months.
| Period | BDEC | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $116 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $143 | $147 |
| 5 years (Aug 2021 – Jul 2026) | $160 | $143 |
| Since data start (Feb 2020 – Jul 2026) | $198 | $169 |
BDEC Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.87% |
| 1 year | +16.41% |
| 3 years (annualised) | +12.75% |
| 5 years (annualised) | +9.85% |
BDEC Annual Returns
Calendar-year total returns of Innovator U.S. Equity Buffer ETF - December, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +7.87% |
| 2025 | +14.87% |
| 2024 | +12.60% |
| 2023 | +20.07% |
| 2022 | −9.26% |
| 2021 | +14.95% |
| 2020 (Feb–Dec) | +13.31% |
BDEC Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.1% | −0.5% | −3.6% | +7.5% | +3.3% | −0.3% | +0.5% | — | — | — | — | — |
| 2025 | +1.8% | −0.9% | −3.9% | −0.6% | +4.5% | +3.7% | +1.9% | +1.6% | +2.8% | +1.8% | +1.0% | +0.4% |
| 2024 | +1.3% | +3.1% | +1.6% | −1.8% | +3.4% | +1.6% | +0.7% | +1.2% | +0.8% | +0.5% | +1.1% | −1.4% |
| 2023 | +5.0% | −2.1% | +3.0% | +1.4% | +0.2% | +5.4% | +3.0% | −1.7% | −4.5% | −2.1% | +8.2% | +3.3% |
| 2022 | −3.3% | −2.1% | +2.6% | −6.3% | +0.7% | −5.2% | +6.4% | −2.2% | −6.8% | +7.0% | +5.3% | −4.4% |
| 2021 | −1.2% | +1.6% | +3.6% | +2.4% | +0.8% | +1.1% | +0.6% | +0.9% | −0.7% | +1.7% | +0.2% | +3.0% |
| 2020 | — | −5.9% | −9.4% | +9.1% | +4.2% | +0.9% | +4.0% | +3.6% | −1.5% | −0.9% | +7.2% | +2.8% |
BDEC Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 9.41%
- 3-year Sharpe ratio: 0.88 (vs 4.5% risk-free rate)
- Best month: +8.24% (Nov 2023)
- Worst month: −4.53% (Sep 2023)
BDEC Fund Flows
Monthly money in and out of Innovator U.S. Equity Buffer ETF - December, from SEC Form N-PORT.
- 12-month net flow: −$33.3M
- 12-month gross sales (incl. reinvestments): $278.4M
- Sales ÷ redemptions: 0.89×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $2.7M | −$2.7M |
| Jun 2026 | $4.0M | $48.9M | −$44.9M |
| May 2026 | $9.3M | $0 | $9.3M |
| Apr 2026 | $2.4M | $2.4M | $46K |
| Mar 2026 | $0 | $3.7M | −$3.7M |
| Feb 2026 | $2.5M | $0 | $2.5M |
| Jan 2026 | $2.5M | $5.0M | −$2.5M |
| Dec 2025 | $51.8M | $0 | $51.8M |
| Nov 2025 | $190.7M | $194.8M | −$4.0M |
| Oct 2025 | $0 | $24.0M | −$24.0M |
| Sep 2025 | $15.2M | $2.4M | $12.8M |
| Aug 2025 | $0 | $27.9M | −$27.9M |
BDEC Assets Under Management
Net assets of Innovator U.S. Equity Buffer ETF - December by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $217.75M |
| 2026-04-30 | $247.92M |
| 2026-01-31 | $241.58M |
| 2025-10-31 | $189.22M |
| 2025-07-31 | $215.77M |
| 2025-04-30 | $191.25M |
| 2025-01-31 | $336.91M |
| 2024-10-31 | $125.50M |
| 2024-07-31 | $134.05M |
| 2024-04-30 | $147.68M |
| 2024-01-31 | $147.40M |
| 2023-10-31 | $95.93M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.